Michinori Ogura Selected Research

Bendamustine Hydrochloride

5/2022	Bendamustine plus rituximab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma.
1/2022	A phase I/II study of 10-min dosing of bendamustine hydrochloride (rapid infusion formulation) in patients with previously untreated indolent B-cell non-Hodgkin lymphoma, mantle cell lymphoma, or relapsed/refractory diffuse large B-cell lymphoma in Japan.
4/2017	Bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or mantle cell lymphoma: a multicenter Phase II clinical trial in Japan.
1/2016	Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel - an update.
2/2015	Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B-cell lymphoma.
6/2013	Multicenter phase II study of bendamustine plus rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma.
3/2013	Rituximab plus bendamustine for the treatment of aggressive non-hodgkin lymphoma patients with severe liver impairment.
5/2012	[II. Treatment trend and outlook on bendamustine for mantle cell lymphoma and follicular lymphoma].
9/2011	Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma.
2/2011	Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine: a multicenter study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michinori Ogura Research Topics

Disease

31	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 12/2002
26	Lymphoma (Lymphomas) 01/2021 - 03/2002
24	Neoplasms (Cancer) 01/2022 - 03/2002
17	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 03/2005
12	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2022 - 03/2005
12	B-Cell Lymphoma (Lymphoma, B Cell) 09/2021 - 02/2003
11	Neutropenia 02/2021 - 01/2008
11	Thrombocytopenia (Thrombopenia) 02/2021 - 01/2008
10	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022 - 09/2010
8	Multiple Myeloma 06/2019 - 01/2008
7	Hodgkin Disease (Hodgkin's Disease) 04/2021 - 03/2005
7	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 02/2021 - 03/2010
7	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2019 - 05/2013
6	Lymphopenia (Lymphocytopenia) 02/2021 - 08/2010
6	Disease Progression 12/2016 - 01/2008
5	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 04/2021 - 06/2003
5	Infections 04/2019 - 10/2004
5	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2016 - 03/2010
5	Leukopenia 12/2016 - 08/2010
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2019 - 11/2007
4	Exanthema (Rash) 03/2018 - 02/2009
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018 - 09/2011
4	Febrile Neutropenia 12/2017 - 12/2009
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2017 - 10/2004
4	Anemia 01/2016 - 10/2006
4	Leukemia 02/2009 - 04/2002
3	Nausea 04/2019 - 08/2010
3	Diarrhea 04/2019 - 10/2004
3	Rheumatoid Arthritis 11/2018 - 05/2017
3	Fatigue 03/2018 - 10/2006
3	Pneumonia (Pneumonitis) 12/2017 - 11/2010
3	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 11/2017 - 07/2012
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2014 - 02/2003
3	Breast Neoplasms (Breast Cancer) 01/2008 - 04/2002
2	Vomiting 04/2019 - 02/2012
2	Hypoalbuminemia 03/2018 - 12/2017
2	Pleural Effusion (Pleural Effusions) 06/2017 - 02/2012
2	Hematologic Neoplasms (Hematological Malignancy) 05/2017 - 07/2015
2	Nasopharyngitis 01/2016 - 11/2010
2	T-Cell Lymphoma (Lymphoma, T Cell) 04/2014 - 06/2003
2	Anorexia 08/2010 - 02/2009
2	Colorectal Neoplasms (Colorectal Cancer) 08/2010 - 04/2002

Drug/Important Bio-Agent (IBA)

46	Rituximab (Mabthera)FDA Link 05/2022 - 03/2002
12	Bendamustine Hydrochloride FDA Link 05/2022 - 09/2010
10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2008
9	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 12/2010
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 12/2010
8	Monoclonal AntibodiesIBA 06/2019 - 03/2002
7	Prednisone (Sone)FDA LinkGeneric 01/2021 - 10/2011
6	CT-P10IBA 01/2022 - 05/2017
6	Pharmaceutical PreparationsIBA 02/2021 - 10/2004
6	Biosimilar PharmaceuticalsIBA 01/2021 - 05/2017
6	Inotuzumab OzogamicinIBA 01/2018 - 08/2010
6	Cladribine FDA LinkGeneric 02/2011 - 02/2003
5	AntibodiesIBA 01/2020 - 03/2002
5	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2018 - 02/2003
5	Cytarabine (Cytosar-U)FDA LinkGeneric 09/2018 - 11/2007
5	Bortezomib (Velcade)FDA Link 01/2016 - 01/2008
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 09/2011
4	ofatumumab FDA Link 08/2017 - 05/2013
4	Imatinib Mesylate (Gleevec)FDA Link 06/2017 - 10/2004
4	Dexamethasone (Maxidex)FDA LinkGeneric 02/2017 - 01/2008
4	CalicheamicinsIBA 10/2016 - 05/2009
4	Prednisolone (Predate)FDA LinkGeneric 01/2016 - 12/2010
3	Brentuximab VedotinIBA 04/2021 - 07/2014
3	EnzymesIBA 04/2019 - 04/2002
3	Alanine Transaminase (SGPT)IBA 03/2018 - 10/2004
3	Dasatinib (BMS 354825)FDA Link 06/2017 - 02/2012
3	Melphalan (Alkeran)FDA LinkGeneric 01/2016 - 12/2009
3	mogamulizumabIBA 04/2014 - 03/2010
2	Antiviral Agents (Antivirals)IBA 01/2020 - 09/2015
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2020 - 09/2015
2	Biomarkers (Surrogate Marker)IBA 12/2017 - 05/2005
2	Azacitidine (5 Azacytidine)FDA Link 12/2017 - 09/2011
2	Cisplatin (Platino)FDA LinkGeneric 02/2017 - 01/2017
2	Lenalidomide (CC 5013)FDA Link 12/2016 - 03/2016
2	Etoposide (VP 16)FDA LinkGeneric 07/2016 - 01/2008
2	Vorinostat FDA Link 01/2016 - 06/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2015 - 03/2015
2	CCR4 ReceptorsIBA 04/2014 - 03/2012
2	Immunoglobulin G (IgG)IBA 07/2013 - 02/2011
2	Dacarbazine (DIC)FDA LinkGeneric 01/2013 - 12/2010
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2013 - 12/2010
2	Vinblastine (Vinblastine Sulfate)FDA Link 01/2013 - 12/2010
2	Anaplastic Lymphoma KinaseIBA 07/2012 - 06/2003
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2012 - 08/2010
2	Sialic Acid Binding Ig-like Lectin 2IBA 05/2012 - 08/2010
2	purineIBA 02/2011 - 03/2005
2	Transaminases (Aminotransferases)IBA 11/2010 - 01/2008
2	fludarabineIBA 10/2009 - 11/2007

Therapy/Procedure

29	Therapeutics 09/2021 - 03/2002
28	Drug Therapy (Chemotherapy) 09/2021 - 03/2002
7	Stem Cell Transplantation 10/2020 - 03/2005
3	Hematopoietic Stem Cell Transplantation 06/2019 - 07/2013
3	Intravenous Infusions 08/2017 - 07/2009
3	Salvage Therapy 02/2017 - 06/2003
3	Radiotherapy 12/2014 - 03/2002
2	Induction Chemotherapy 10/2020 - 12/2009
2	Radioimmunotherapy 08/2016 - 01/2009
2	Transplantation 07/2013 - 01/2005